Saxagliptin efficacy

Diabetes Obes Metab. 2010 Aug;12(8):734; author reply 735. doi: 10.1111/j.1463-1326.2010.01205.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adamantane / analogs & derivatives*
  • Adamantane / therapeutic use
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptides / therapeutic use*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Postprandial Period
  • Treatment Outcome

Substances

  • Dipeptides
  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • saxagliptin
  • Adamantane